{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:01:11Z","timestamp":1761663671712,"version":"build-2065373602"},"reference-count":66,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T00:00:00Z","timestamp":1559520000000},"content-version":"vor","delay-in-days":579,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Hepatology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.5604\/01.3001.0010.5275","type":"journal-article","created":{"date-parts":[[2017,10,17]],"date-time":"2017-10-17T03:06:23Z","timestamp":1508209583000},"page":"851-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Hepatitis C and Its Metabolic Complications in Kidney Disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Fabrizio","family":"Fabrizi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca M.","family":"Donato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piergiorgio","family":"Messa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl. 109","key":"10.5604\/01.3001.0010.5275_bib0010","first-page":"S1","article-title":"KDIGO clinical practice guidelines for the prevention, diagnosis, evaluation, and treatment of hepatitis C in chronic kidney disease","volume":"73","year":"2008","journal-title":"Kidney Int"},{"key":"10.5604\/01.3001.0010.5275_bib0015","first-page":"1","article-title":"Recommendations for preventing transmission of infections among chronic haemodialysis patients","volume":"5","year":"2001","journal-title":"MMWR"},{"key":"10.5604\/01.3001.0010.5275_bib0020","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1111\/j.1523-1755.2004.00649.x","article-title":"Patterns of hepatitis C prevalence and seroconversion on haemodialysis from three continents: the DOPPS","volume":"65","author":"Fissell","year":"2004","journal-title":"Kidney Int"},{"issue":"5","key":"10.5604\/01.3001.0010.5275_bib0025","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1159\/000355615","article-title":"Hepatitis C infection is very rarely treated among haemodialysis patients","volume":"38","author":"Goodkin","year":"2013","journal-title":"Am J Nephrol"},{"key":"10.5604\/01.3001.0010.5275_bib0030","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1186\/1471-2334-12-265","article-title":"Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors","volume":"12","author":"Alashek","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.5604\/01.3001.0010.5275_bib0035","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1002\/jmv.23486","article-title":"Prevalence and risk factors of hepatitis C and B virus infections in hemodialysis patients and their spouses: a multi-center study in Beijing, China","volume":"85","author":"Su","year":"2013","journal-title":"J Med Virol"},{"key":"10.5604\/01.3001.0010.5275_bib0040","first-page":"305","article-title":"Risk factors for hepatitis C virus seropositivity among hemodialysis patients receiving care at kidney centre in a tertiary health facility in Maiduguri, Nigeria","volume":"19","author":"Unmate","year":"2014","journal-title":"Pan Afr Med J"},{"key":"10.5604\/01.3001.0010.5275_bib0045","first-page":"133","article-title":"Prevalence of seroconversion of hepatitis C virus among hemodialysis patients in Menoufia Governorate, Egypt","volume":"7","author":"Zahran","year":"2014","journal-title":"Arab J Nephrol Transplant"},{"key":"10.5604\/01.3001.0010.5275_bib0050","doi-asserted-by":"crossref","first-page":"672","DOI":"10.4103\/1319-2442.132236","article-title":"Viral hepatitis C and B among dialysis patients at the Rabat University Hospital: prevalence and risk factors","volume":"25","author":"Lioussfi","year":"2014","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.5604\/01.3001.0010.5275_bib0055","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1002\/jmv.24008","article-title":"Prevalence of occult HBV among haemodialysis patients in two districts in the northern part of the West Bank, Palestine","volume":"86","author":"Dumaidi","year":"2014","journal-title":"J Med Virol"},{"key":"10.5604\/01.3001.0010.5275_bib0060","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000371450","article-title":"Hepatitis B and C virus infection in the hemodi-alysis population from three Romanian regions","volume":"129","author":"Schiller","year":"2015","journal-title":"Nephron"},{"key":"10.5604\/01.3001.0010.5275_bib0065","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12889-015-1532-9","article-title":"Hepatitis B and C virus infections among patients with end stage renal disease in a low-resourced hemodialysis center in Vietnam: a cross-sectional study","volume":"15","author":"Duong","year":"2015","journal-title":"BMC Public Health"},{"key":"10.5604\/01.3001.0010.5275_bib0070","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s12985-015-0238-z","article-title":"Detection of hepatitis C virus in patients with terminal renal disease undergoing dialysis in southern Brazil: prevalence, risk factors, genotypes, and viral load dynamics in haemodialysis patients","volume":"12","author":"Vidales-Braz","year":"2015","journal-title":"J Virol"},{"key":"10.5604\/01.3001.0010.5275_bib0075","doi-asserted-by":"crossref","first-page":"380","DOI":"10.4103\/1319-2442.152555","article-title":"Prevalence and associated factors of hepatitis C virus infection among renal disease patients on maintenance hemodialuysis in three health centers in Aden, Yemen: a cross-sectional study","volume":"26","author":"Aman","year":"2015","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.5604\/01.3001.0010.5275_bib0080","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4103\/0976-9668.175076","article-title":"Hepatitis B virus and hepatitis C virus co-infection in haemo-dialysis patients: A retrospective study from a tertiary care hospital of North India","volume":"7","author":"Malhotra","year":"2016","journal-title":"J Nat Sci Biol Med"},{"key":"10.5604\/01.3001.0010.5275_bib0085","first-page":"304","article-title":"Hepatitis B hepatitis C and human immunodeficiency virus seroconversion positivity rates and their potential risk factors among patients on maintenance haemodialysis in Cameroon","volume":"10","author":"Halle","year":"2016","journal-title":"Iran J Kidney Dis"},{"key":"10.5604\/01.3001.0010.5275_bib0090","doi-asserted-by":"crossref","first-page":"e37878","DOI":"10.5812\/numonthly.37878","article-title":"Epidemiological aspects of hepatitis B and C and human immunodeficiency viruses among haemodialysis patients in Mazandaran Province, Iran","volume":"8","author":"Hasanjani Roushan","year":"2016","journal-title":"Nephrourol Mon"},{"key":"10.5604\/01.3001.0010.5275_bib0095","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1159\/000366478","article-title":"Mortality and cardiovascular morbidity associated with haemoglobin levels: a pooled analysis of randomised controlled trials","volume":"128","author":"Locatelli","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"10.5604\/01.3001.0010.5275_bib0100","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2893.2012.01633.x","article-title":"Impact of hepatitis C on survival in dialysis patients: a link with cardiovascular mortality ?","volume":"19","author":"Fabrizi","year":"2012","journal-title":"J Viral Hepat"},{"key":"10.5604\/01.3001.0010.5275_bib0105","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1093\/ndt\/gfh895","article-title":"Clinical characteristics and mortality in hepatitis C-positive haemodialysis patients: a population based study","volume":"20","author":"Kalantar-Zadeh","year":"2005","journal-title":"Nephrol Dial Transplant"},{"key":"10.5604\/01.3001.0010.5275_bib0110","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/TP.0b013e3181f92548","article-title":"Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand","volume":"90","author":"Scott","year":"2010","journal-title":"Transplantation"},{"key":"10.5604\/01.3001.0010.5275_bib0115","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2188\/jea.JE20100187","article-title":"Seropositivity for anti-HCV core antigen is independently associated with increased all-cause, cardiovascular, and liver-disease-related mortality in haemodialysis patients","volume":"21","author":"Ohsawa","year":"2011","journal-title":"J Epidemiology"},{"key":"10.5604\/01.3001.0010.5275_bib0120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2215\/CJN.07940716","article-title":"Mortality, Epidemiology, hospitalization, and quality of life among haemodialysis patients with hepatitis C infection","volume":"12","author":"Goodkin","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.5604\/01.3001.0010.5275_bib0125","doi-asserted-by":"crossref","first-page":"528","DOI":"10.4254\/wjh.v5.i10.528","article-title":"Chronic HCV infection and inflammation: clinical impact on hepatic and extra-hepatic manifestations","volume":"5","author":"Zampino","year":"2013","journal-title":"World J Hepatol"},{"key":"10.5604\/01.3001.0010.5275_bib0130","doi-asserted-by":"crossref","first-page":"3410","DOI":"10.3748\/wjg.v20.i13.3410","article-title":"Chronic hepatitis C virus infection and atherosclerosis: clinical impact and mechanisms","volume":"20","author":"Adinolfi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"Suppl. 2","key":"10.5604\/01.3001.0010.5275_bib0135","doi-asserted-by":"crossref","first-page":"S782","DOI":"10.1007\/s12072-013-9460-1","article-title":"Insulin resistance, steatosis and hepatitis C virus","volume":"7","author":"Mangia","year":"2013","journal-title":"Hepatol Int"},{"key":"10.5604\/01.3001.0010.5275_bib0140","article-title":"Atherosclerosis as extra-hepatic manifestation of chronic infection with hepatitis C virus","volume":"7629318","author":"Voulgaris","year":"2016","journal-title":"Hep Res Treatment"},{"key":"10.5604\/01.3001.0010.5275_bib0145","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.4254\/wjh.v7.i19.2214","article-title":"Assessing cardiovascular risk in hepatitis C: An unmet need","volume":"8","author":"Ampuero","year":"2015","journal-title":"World J Hepatol"},{"key":"10.5604\/01.3001.0010.5275_bib0150","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1053\/j.gastro.2015.09.007","article-title":"Hepatitis C virus infection is associated with increased cardiovascular mortality: A meta-analysis of observational studies","volume":"150","author":"Petta","year":"2016","journal-title":"Gastroenterology"},{"key":"10.5604\/01.3001.0010.5275_bib0155","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1007\/s10620-015-3801-y","article-title":"Hepatitis C virus infection increases the risk of developing chronic kidney disease: A systematic review and meta-analysis","volume":"60","author":"Fabrizi","year":"2015","journal-title":"Dig Dis Sci"},{"key":"10.5604\/01.3001.0010.5275_bib0160","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1523-1755.2005.00080.x","article-title":"Relationship between hepatitis C and microalbuminuria: results from the NHANES III","volume":"67","author":"Liangpunsakul","year":"2005","journal-title":"Kidney Int"},{"key":"10.5604\/01.3001.0010.5275_bib0165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1365-2796.2006.01686.x","article-title":"Viral hepatitis and proteinuria in an area endemic for hepatitis B and C infections: another chain of link?","volume":"260","author":"Huang","year":"2006","journal-title":"J Intern Med"},{"key":"10.5604\/01.3001.0010.5275_bib0170","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1681\/ASN.2005091006","article-title":"Relationship between hepatitis C and chronic kidney disease: results from the Third National Health and Nutrition Examination Survey","volume":"17","author":"Tsui","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.5604\/01.3001.0010.5275_bib0175","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/j.1872-034X.2008.00334.x","article-title":"Association between hepatitis B\/C viral infection, chronic kidney disease and insulin resistance in individuals undergoing general health screening","volume":"38","author":"Ishizaka","year":"2008","journal-title":"Hepatol Res"},{"key":"10.5604\/01.3001.0010.5275_bib0180","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.2215\/CJN.01030210","article-title":"HIV and pro-teinuria in an injection drug user population","volume":"5","author":"Yanik","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.5604\/01.3001.0010.5275_bib0185","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.ajkd.2010.01.015","article-title":"Association of hepatitis C and B virus infection with chronic kidney disease in an endemic area in Taiwan. A cross-sectional study","volume":"56","author":"Lee","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.5604\/01.3001.0010.5275_bib0190","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/cts.12321","article-title":"Association of hepatitis C virus infection with proteinuria and glomerular filtration rate","volume":"8","author":"Kurbanova","year":"2015","journal-title":"Clin Transl Sci"},{"key":"10.5604\/01.3001.0010.5275_bib0195","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/archinte.167.12.1271","article-title":"Association of hepatitis C seropositivity with increased risk for developing end-stage renal disease","volume":"167","author":"Tsui","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.5604\/01.3001.0010.5275_bib0200","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1053\/j.ajkd.2008.03.009","article-title":"Association of hepatitis C virus infection with prevalence and development of kidney disease","volume":"51","author":"Moe","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.5604\/01.3001.0010.5275_bib0205","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cgh.2009.08.031","article-title":"Lack of association between hepatitis C infection and chronic kidney disease","volume":"8","author":"Asrani","year":"2010","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.5604\/01.3001.0010.5275_bib0210","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2215\/CJN.00470107","article-title":"Hepatitis C virus infection and the prevalence of renal insufficiency","volume":"2","author":"Dalrymple","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.5604\/01.3001.0010.5275_bib0215","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/infdis\/jit373","article-title":"for the NA-ACCORD of the IeDEA. Hepatitis C viremia and the risk of chronic kidney disease in HIV-in-fected individuals","volume":"208","author":"Lucas","year":"2013","journal-title":"J Infect Dis"},{"key":"10.5604\/01.3001.0010.5275_bib0220","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/s12072-011-9284-9","article-title":"Higher prevalence of chronic kidney disease and shorter renal survival in patients with chronic hepatitis C virus infection","volume":"6","author":"Satapathy","year":"2012","journal-title":"Hepatol Int"},{"key":"10.5604\/01.3001.0010.5275_bib0225","first-page":"583","article-title":"Arterites infectieuses experimentales","volume":"41","author":"Gilbert","year":"1889","journal-title":"C R Hebd Seances Soc Biol Fil"},{"key":"10.5604\/01.3001.0010.5275_bib0230","first-page":"85","article-title":"Infection and atherosclerosis. An alternative view on an outdated hypothesis","volume":"60","author":"Stassen","year":"2008","journal-title":"Pharmacol Rep"},{"key":"10.5604\/01.3001.0010.5275_bib0235","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jcv.2009.10.005","article-title":"Hepatitis C virus RNA localization in human carotid plaques","volume":"47","author":"Boddi","year":"2010","journal-title":"J Clin Virol"},{"key":"10.5604\/01.3001.0010.5275_bib0240","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1681\/ASN.V114690","article-title":"High prevalence and adverse effects of hepatitis C virus infection in type II diabetic-related nephropa-thy","volume":"11","author":"Soma","year":"2000","journal-title":"J Am Soc Nephrol"},{"key":"10.5604\/01.3001.0010.5275_bib0245","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.2337\/diacare.28.9.2187","article-title":"Hepatitis C is a predictor of poorer renal survival in diabetic patients","volume":"298","author":"Crook","year":"2005","journal-title":"Diabetes Care"},{"key":"10.5604\/01.3001.0010.5275_bib0250","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1159\/000319456","article-title":"Hepatitis C increases the risk of progression of chronic kidney disease in patients with glomerulonephritis","volume":"32","author":"Noureddine","year":"2010","journal-title":"Am J Nephrol"},{"key":"10.5604\/01.3001.0010.5275_bib0255","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/lt.23756","article-title":"Improved renal function in liver transplant recipients treated for hepatitis C virus with a sustained viro-logical response and mild chronic kidney disease","volume":"20","author":"Ble","year":"2014","journal-title":"Liver Transpl"},{"key":"10.5604\/01.3001.0010.5275_bib0260","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1053\/j.ajkd.2004.12.014","article-title":"Hepatitis C infection is acquired pre-ESRD","volume":"45","author":"Bergman","year":"2005","journal-title":". Am J Kidney Dis"},{"key":"10.5604\/01.3001.0010.5275_bib0265","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10157-007-0005-6","article-title":"Patterns in the prevalence of hepatitis C virus infection at the start of haemodialysis in Japan","volume":"12","author":"Iwasa","year":"2008","journal-title":"Clin Exp Nephrol"},{"key":"10.5604\/01.3001.0010.5275_bib0270","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1053\/j.ajkd.2009.02.009","article-title":"Hepatitis C seropositivity and kidney function decline among women with HIV: data from the Women\u2019s Interagency HIV Study","volume":"54","author":"Tsui","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"10.5604\/01.3001.0010.5275_bib0275","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/QAD.0b013e32830e0152","article-title":"The impact of hepatitis C virus coinfection on HIV-related kidney disease: a systematic review and meta-analysis","volume":"22","author":"Wyatt","year":"2008","journal-title":"AIDS"},{"key":"10.5604\/01.3001.0010.5275_bib0280","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jmv.24353","article-title":"Hepatitis C virus increases the risk of kidney disease among HIV-positive patients: systematic review and meta-analysis","volume":"88","author":"Fabrizi","year":"2016","journal-title":"J Med Virol"},{"key":"10.5604\/01.3001.0010.5275_bib0285","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1089\/apc.2012.0170","article-title":"Health care utilization in HIV-infected patients: Assessing the burden of hepatitis C virus co-infection","volume":"26","author":"Norton","year":"2012","journal-title":"AIDS Patient Care and STDs"},{"key":"10.5604\/01.3001.0010.5275_bib0290","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1093\/aje\/kwm061","article-title":"Hepatitis C virus infection and the development of type 2 diabetes in a community-based longitudinal study","volume":"166","author":"Wang","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.5604\/01.3001.0010.5275_bib0295","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1089\/jir.2014.0200","article-title":"Clearance of hepatitis C virus improves insulin resistance during and after peginterferon and ribavirin therapy","volume":"35","author":"Chien","year":"2015","journal-title":"J Interferon Cytokine Res"},{"key":"10.5604\/01.3001.0010.5275_bib0300","first-page":"e1001680","article-title":"Association of non \u2013alco-holic fatty liver disease with chronic kidney disease: A systematic review and meta-analysis","volume":"11","author":"Musso","year":"2014","journal-title":"PLOs One"},{"key":"10.5604\/01.3001.0010.5275_bib0305","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/apt.12391","article-title":"Inter-feron-based therapy reduces risk of stroke in chronic hepatitis C patients: a population based cohort study in Taiwan","volume":"38","author":"Hsu","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.5604\/01.3001.0010.5275_bib0310","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1093\/cid\/cis500","article-title":"; GESIDA HIV\/ HCV Cohort Study Group. Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients co-infected with HIV and hepatitis C virus","volume":"55","author":"Berenguer","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.5604\/01.3001.0010.5275_bib0315","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1136\/gutjnl-2014-308163","article-title":"Association between antiviral treatment and extra-hepatic outcomes in patients with hepatitis C virus infection","volume":"64","author":"Hsu","year":"2015","journal-title":"Gut"},{"key":"10.5604\/01.3001.0010.5275_bib0320","doi-asserted-by":"crossref","first-page":"e1334","DOI":"10.1097\/MD.0000000000001334","article-title":"A Taiwanese nationwide cohort study shows interferon-based therapy for chronic hepatitis C reduces the risk of chronic kidney disease","volume":"94","author":"Chen","year":"2015","journal-title":"Medicine"},{"key":"10.5604\/01.3001.0010.5275_bib0325","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/hep.26892","article-title":"Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patients","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"},{"key":"10.5604\/01.3001.0010.5275_bib0330","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/j.1872-034X.2011.00845.x","article-title":"Development rate of chronic kidney disease in hepatitis C virus patients with advanced fibrosis after interferon therapy","volume":"41","author":"Arase","year":"2011","journal-title":"Hepatol Res"},{"key":"10.5604\/01.3001.0010.5275_bib0335","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1007\/s10096-016-2692-y","article-title":"Incidence and predictors of cardiovascular disease, chronic kidney disease, and diabetes in HIV\/HCV \u2013coinfected patients who achieved sustained virological response","volume":"35","author":"Leone","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"}],"container-title":["Annals of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526811930451X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S166526811930451X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:36:36Z","timestamp":1761647796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S166526811930451X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11]]},"references-count":66,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S166526811930451X"],"URL":"https:\/\/doi.org\/10.5604\/01.3001.0010.5275","relation":{},"ISSN":["1665-2681"],"issn-type":[{"type":"print","value":"1665-2681"}],"subject":[],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C and Its Metabolic Complications in Kidney Disease","name":"articletitle","label":"Article Title"},{"value":"Annals of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.5604\/01.3001.0010.5275","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2017 Fundaci\u00f3n Cl\u00ednica M\u00e9dica Sur, A.C. Published by Elsevier Espa\u00f1a, S.L.","name":"copyright","label":"Copyright"}]}}